Novartis AG

Novartis AG is a leading multinational pharmaceutical corporation headquartered in Basel, Switzerland. The company is recognized as one of the world’s largest healthcare firms, ranking eighth globally by revenue in 2024. Novartis AG focuses on the research, development, manufacturing, and marketing of pharmaceutical drugs, including both innovative medicines and generics. Its operations are organized into two main divisions: Innovative Medicines, which covers branded pharmaceuticals and oncology, and Sandoz, which handled generics prior to its spin-off in 2023. The company’s products address a broad range of therapeutic areas such as oncology, immunology, neuroscience, cardiology, and ophthalmology, impacting healthcare across global markets. Novartis serves patients in over 100 countries and employs more than 75,000 people worldwide. Known for its significant investment in research and development, Novartis AG plays a critical role in advancing medical science and making innovative treatments accessible to patients around the world.